Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics
Stock Information for Acurx Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.